• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本肝硬化的病因:一项全国性调查。

Etiology of liver cirrhosis in Japan: a nationwide survey.

机构信息

Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.

出版信息

J Gastroenterol. 2010;45(1):86-94. doi: 10.1007/s00535-009-0128-5. Epub 2009 Sep 30.

DOI:10.1007/s00535-009-0128-5
PMID:19789837
Abstract

BACKGROUND

Little is understood about worldwide changes in the epidemiological distribution of the etiology of liver cirrhosis (LC). The present study examines the etiology of liver cirrhosis in Japan using a nationwide survey.

METHODS

We analyzed data from 33,379 patients with LC at 58 hospitals and presented the findings in a poster symposium regarding the etiology and clinical features of LC in Japan that was included in the program of the 44th Annual Meeting of the Japan Society of Hepatology. We identified the distribution of the etiology of LC and compared the present with previous Japanese findings to estimate the future of etiological changes in LC.

RESULTS

The etiological agents were as follows: hepatitis B virus (HBV) 13.9%, hepatitis C virus (HCV) 60.9%, alcohol 13.6%, primary biliary cirrhosis (PBC) 2.4% and autoimmune hepatitis (AIH) 1.9%. Cirrhosis was considered to be related to nonalcoholic steatohepatitis (NASH) in 2.1% of the patients. The ratio of HCV-related LC was significantly higher among patients with hepatocellular carcinoma (HCC) (P < 0.0001) compared to those without, whereas the ratios of alcohol, PBC, AIH were lower. HCC was evident in 31.5% of NASH-related LC.

CONCLUSIONS

The major etiology of liver cirrhosis in Japan remains HCV. Our survey revealed the prevalence of NASH-related LC in Japan and the frequency of HCC. Future changes in etiology must be considered in establishing preventive or educational strategies, as well as in developing new treatment strategies.

摘要

背景

关于全球范围内肝硬化(LC)病因学的流行病学分布变化,人们知之甚少。本研究使用一项全国性调查,考察了日本 LC 的病因。

方法

我们分析了 58 家医院的 33379 例 LC 患者的数据,并在日本 LC 的病因和临床特征海报研讨会上展示了研究结果,该研讨会被列入第 44 届日本肝脏研究学会年会的计划。我们确定了 LC 病因的分布,并将目前的情况与以前的日本发现进行了比较,以估计 LC 病因变化的未来。

结果

病因如下:乙型肝炎病毒(HBV)13.9%、丙型肝炎病毒(HCV)60.9%、酒精 13.6%、原发性胆汁性肝硬化(PBC)2.4%和自身免疫性肝炎(AIH)1.9%。2.1%的患者认为肝硬化与非酒精性脂肪性肝炎(NASH)有关。在 HCC 患者中,HCV 相关 LC 的比例明显高于无 HCC 患者(P<0.0001),而酒精、PBC 和 AIH 的比例较低。NASH 相关 LC 中有 31.5%的患者有 HCC。

结论

日本 LC 的主要病因仍然是 HCV。我们的调查揭示了日本 NASH 相关 LC 的流行情况和 HCC 的发生频率。在制定预防或教育策略以及开发新的治疗策略时,必须考虑病因的未来变化。

相似文献

1
Etiology of liver cirrhosis in Japan: a nationwide survey.日本肝硬化的病因:一项全国性调查。
J Gastroenterol. 2010;45(1):86-94. doi: 10.1007/s00535-009-0128-5. Epub 2009 Sep 30.
2
The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan.日本全国性调查中肝细胞癌合并肝硬化病因的转变。
J Gastroenterol. 2021 Feb;56(2):158-167. doi: 10.1007/s00535-020-01748-x. Epub 2020 Nov 20.
3
Study of liver cirrhosis over ten consecutive years in Southern China.中国南方地区连续十年肝硬化研究。
World J Gastroenterol. 2014 Oct 7;20(37):13546-55. doi: 10.3748/wjg.v20.i37.13546.
4
Transition in the etiology of liver cirrhosis in Japan: a nationwide survey.日本肝硬化病因变迁:一项全国性调查。
J Gastroenterol. 2020 Mar;55(3):353-362. doi: 10.1007/s00535-019-01645-y. Epub 2019 Nov 25.
5
Risk of development of hepatocellular carcinoma in patients with NASH-related cirrhosis.非酒精性脂肪性肝炎相关肝硬化患者发生肝细胞癌的风险。
Trop Gastroenterol. 2013 Jul-Sep;34(3):159-63. doi: 10.7869/tg.120.
6
The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者肝细胞癌的发病率及危险因素。
Hepatology. 2010 Jun;51(6):1972-8. doi: 10.1002/hep.23527.
7
Hepatitis C virus infection in alcoholic liver cirrhosis in Japan: its contribution to the development of hepatocellular carcinoma.日本酒精性肝硬化患者中的丙型肝炎病毒感染:其在肝细胞癌发生中的作用
Alcohol Alcohol Suppl. 1993;1A:85-90. doi: 10.1093/alcalc/28.supplement_1a.85.
8
Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.非酒精性脂肪性肝炎所致肝硬化与慢性丙型肝炎所致肝硬化的临床特征及转归比较
J Gastroenterol Hepatol. 2009 Feb;24(2):248-54. doi: 10.1111/j.1440-1746.2008.05640.x. Epub 2008 Nov 20.
9
Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.日本非酒精性脂肪性肝病中的肝癌发生。
J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:88-92. doi: 10.1111/jgh.12239.
10
Survey of non-B, non-C liver cirrhosis in Japan.日本非乙型、非丙型肝硬化调查。
Hepatol Res. 2013 Oct;43(10):1020-31. doi: 10.1111/hepr.12056. Epub 2013 Jan 25.

引用本文的文献

1
Poor Abilities of Noninvasive Biomarkers to Assess Esophagogastric Varices and Portal Hypertensive Gastropathy.非侵入性生物标志物评估食管胃静脉曲张和门静脉高压性胃病的能力欠佳。
Biomark Insights. 2025 May 16;20:11772719251339185. doi: 10.1177/11772719251339185. eCollection 2025.
2
Multiomics Analysis of Liver Molecular Dysregulation Leading to Nonviral-Related Hepatocellular Carcinoma Development.导致非病毒相关性肝细胞癌发生的肝脏分子失调的多组学分析
J Proteome Res. 2025 Mar 7;24(3):1102-1117. doi: 10.1021/acs.jproteome.4c00729. Epub 2025 Feb 21.
3
Outcomes after laparoscopic or open liver resection for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: a propensity score-matching study.

本文引用的文献

1
Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.非酒精性脂肪性肝炎所致肝硬化与慢性丙型肝炎所致肝硬化的临床特征及转归比较
J Gastroenterol Hepatol. 2009 Feb;24(2):248-54. doi: 10.1111/j.1440-1746.2008.05640.x. Epub 2008 Nov 20.
2
The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance.美国胃肠病学实践中新诊断慢性肝病的流行病学:基于人群监测的结果
Am J Gastroenterol. 2008 Nov;103(11):2727-36; quiz 2737. doi: 10.1111/j.1572-0241.2008.02071.x. Epub 2008 Jul 31.
3
腹腔镜或开腹肝切除治疗非酒精性脂肪性肝病相关肝细胞癌的疗效比较:一项倾向评分匹配研究。
Surg Endosc. 2024 Jul;38(7):3887-3904. doi: 10.1007/s00464-024-10937-1. Epub 2024 Jun 3.
4
Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes.肝癌发病率和治疗效果的种族差异。
Cancer Rep (Hoboken). 2023 Sep;6 Suppl 1(Suppl 1):e1821. doi: 10.1002/cnr2.1821. Epub 2023 Jun 21.
5
Hematological Abnormalities in Cirrhosis: A Narrative Review.肝硬化中的血液学异常:一篇叙述性综述。
Cureus. 2023 May 19;15(5):e39239. doi: 10.7759/cureus.39239. eCollection 2023 May.
6
Clinicopathological features of 11 cases of chronic hepatitis B infection complicated with primary biliary cholangitis.11例慢性乙型肝炎感染合并原发性胆汁性胆管炎的临床病理特征
World J Hepatol. 2023 Apr 27;15(4):577-584. doi: 10.4254/wjh.v15.i4.577.
7
Spontaneous Retroperitoneal Hematoma: A Deadly Complication for Patients Awaiting Liver Transplant.自发性腹膜后血肿:肝移植等待患者的致命并发症
Cureus. 2022 Dec 14;14(12):e32522. doi: 10.7759/cureus.32522. eCollection 2022 Dec.
8
The burden of liver cirrhosis in mortality: Results from the global burden of disease study.肝硬化在死亡率中的负担:来自全球疾病负担研究的结果。
Front Public Health. 2022 Aug 11;10:909455. doi: 10.3389/fpubh.2022.909455. eCollection 2022.
9
Comparison of Risk Factors for Cholangiocarcinoma and Hepatocellular Carcinoma: A Prospective Cohort Study in Korean Adults.胆管癌和肝细胞癌危险因素的比较:一项针对韩国成年人的前瞻性队列研究。
Cancers (Basel). 2022 Mar 28;14(7):1709. doi: 10.3390/cancers14071709.
10
Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity.非酒精性脂肪性肝病的异质性:对临床实践和研究活动的影响。
World J Hepatol. 2021 Nov 27;13(11):1584-1610. doi: 10.4254/wjh.v13.i11.1584.
Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: a general population-based study.
1992 - 2001年英国肝硬化的发病率和患病率:一项基于普通人群的研究。
J Hepatol. 2008 Nov;49(5):732-8. doi: 10.1016/j.jhep.2008.05.023. Epub 2008 Jun 25.
4
Incidence rates of hepatitis B and C virus infections among blood donors in Hiroshima, Japan, during 10 years from 1994 to 2004.1994年至2004年的10年间,日本广岛献血者中乙型和丙型肝炎病毒感染的发病率。
Intervirology. 2008;51(1):33-41. doi: 10.1159/000118794. Epub 2008 Feb 29.
5
Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment.传统推导的慢性肝病死亡率的局限性:全面评估结果
Hepatology. 2008 Apr;47(4):1150-7. doi: 10.1002/hep.22181.
6
Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world's longest-lived people and its potential impact on morbidity and life span.热量限制、传统冲绳饮食与健康衰老:世界最长寿人群的饮食及其对发病率和寿命的潜在影响。
Ann N Y Acad Sci. 2007 Oct;1114:434-55. doi: 10.1196/annals.1396.037.
7
Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan.日本第 17 次原发性肝癌全国随访调查报告。
Hepatol Res. 2007 Sep;37(9):676-91. doi: 10.1111/j.1872-034X.2007.00119.x.
8
Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study.代谢综合征对日本普通人群心血管疾病发生的影响:久山研究
Stroke. 2007 Jul;38(7):2063-9. doi: 10.1161/STROKEAHA.106.479642. Epub 2007 May 24.
9
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.全球范围内乙型肝炎病毒和丙型肝炎病毒感染对肝硬化和原发性肝癌的影响。
J Hepatol. 2006 Oct;45(4):529-38. doi: 10.1016/j.jhep.2006.05.013. Epub 2006 Jun 23.
10
Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.乙型肝炎和丙型肝炎低流行地区肝细胞癌的流行病学
Oncogene. 2006 Jun 26;25(27):3771-7. doi: 10.1038/sj.onc.1209560.